Boehringer Ingelheim makes its best molecules available to the scientific community
Boehringer Ingelheim has announced the launch of a new platform…
Boehringer Ingelheim has announced the launch of a new platform offering free and open access to selected pre-clinical molecules for a non-clinical investigation to scientists worldwide...